The North America Dermatology Imaging Devices Market would witness market growth of 11.8% CAGR during the forecast period (2023-2030).
The US market dominated the North America Dermatology Imaging Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,470.3 million by 2030. The Canada market is experiencing a CAGR of 14.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 13.3% during (2023 - 2030).
Patients are more proactive and knowledgeable about their skin health in recent times. Increased awareness about the importance of early detection of skin conditions, especially skin cancers, has led to a higher demand for advanced diagnostic methods. Dermatology imaging devices, offering non-invasive and detailed assessments, resonate well with patients who seek more comprehensive and technology-driven healthcare solutions. It has seamlessly integrated into the standard protocols of dermatological practices. They are no longer perceived as niche or experimental tools but have become routine components of dermatological examinations. This integration reflects healthcare professionals' confidence in the reliability and efficacy of these devices for diagnostic and monitoring purposes.
The ability to capture and transmit high-quality images remotely has facilitated teleconsultations, enabling dermatologists to provide expert opinions without needing in-person visits. This has improved access to specialized care and expanded the reach of dermatological services, particularly in underserved or remote areas. It generates a wealth of data that can be leveraged for evidence-based decision-making. Healthcare providers increasingly recognize this data's value in tailoring treatment plans, monitoring progress, and optimizing patient outcomes. The shift towards a more data-driven approach in dermatology has driven the adoption of imaging devices as essential tools in the diagnostic and therapeutic arsenal.
The aging population in Canada is more prone to various age-related skin conditions, including skin cancers, dermatitis, and other dermatological issues. In Canada, the elderly population commonly experiences chronic skin conditions and dermatological diseases, such as psoriasis, eczema, and fungal infections. The increasing prevalence of dermatological issues in older people has led to a growing specialization in geriatric dermatology in Canada. According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Hence, the factors mentioned above will drive the regional market growth.
Based on End-use, the market is segmented into Hospitals, Dermatology Centers, and Specialty Clinics. Based on Modality, the market is segmented into Dermatoscope, Digital Photographic Imaging, Optical Coherence Tomography (OCT), High Frequency Ultrasound, and Others. Based on Application, the market is segmented into Skin Cancers, Inflammatory Dermatoses, Plastic & Reconstructive Surgery, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Dermatology Imaging Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,470.3 million by 2030. The Canada market is experiencing a CAGR of 14.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 13.3% during (2023 - 2030).
Patients are more proactive and knowledgeable about their skin health in recent times. Increased awareness about the importance of early detection of skin conditions, especially skin cancers, has led to a higher demand for advanced diagnostic methods. Dermatology imaging devices, offering non-invasive and detailed assessments, resonate well with patients who seek more comprehensive and technology-driven healthcare solutions. It has seamlessly integrated into the standard protocols of dermatological practices. They are no longer perceived as niche or experimental tools but have become routine components of dermatological examinations. This integration reflects healthcare professionals' confidence in the reliability and efficacy of these devices for diagnostic and monitoring purposes.
The ability to capture and transmit high-quality images remotely has facilitated teleconsultations, enabling dermatologists to provide expert opinions without needing in-person visits. This has improved access to specialized care and expanded the reach of dermatological services, particularly in underserved or remote areas. It generates a wealth of data that can be leveraged for evidence-based decision-making. Healthcare providers increasingly recognize this data's value in tailoring treatment plans, monitoring progress, and optimizing patient outcomes. The shift towards a more data-driven approach in dermatology has driven the adoption of imaging devices as essential tools in the diagnostic and therapeutic arsenal.
The aging population in Canada is more prone to various age-related skin conditions, including skin cancers, dermatitis, and other dermatological issues. In Canada, the elderly population commonly experiences chronic skin conditions and dermatological diseases, such as psoriasis, eczema, and fungal infections. The increasing prevalence of dermatological issues in older people has led to a growing specialization in geriatric dermatology in Canada. According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Hence, the factors mentioned above will drive the regional market growth.
Based on End-use, the market is segmented into Hospitals, Dermatology Centers, and Specialty Clinics. Based on Modality, the market is segmented into Dermatoscope, Digital Photographic Imaging, Optical Coherence Tomography (OCT), High Frequency Ultrasound, and Others. Based on Application, the market is segmented into Skin Cancers, Inflammatory Dermatoses, Plastic & Reconstructive Surgery, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Canfield Scientific, Inc.
- FotoFinder Systems GmbH
- Courage + Khazaka electronic GmbH
- FUJIFILM VisualSonics, Inc. (Fujifilm Holdings Corporation)
- Longport, Inc.
- Michelson Diagnostics Ltd
- DRAMINSKI S. A.
- Cortex Technology ApS
Market Report Segmentation
By End-use- Hospitals
- Dermatology Centers
- Specialty Clinics
- Dermatoscope
- Digital Photographic Imaging
- Optical Coherence Tomography (OCT)
- High Frequency Ultrasound
- Others
- Skin Cancers
- Inflammatory Dermatoses
- Plastic & Reconstructive Surgery
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. North America Dermatology Imaging Devices Market by End-use
Chapter 6. North America Dermatology Imaging Devices Market by Modality
Chapter 7. North America Dermatology Imaging Devices Market by Application
Chapter 8. North America Dermatology Imaging Devices Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Canfield Scientific, Inc.
- FotoFinder Systems GmbH
- Courage + Khazaka electronic GmbH
- FUJIFILM VisualSonics, Inc. (Fujifilm Holdings Corporation)
- Longport, Inc.
- Michelson Diagnostics Ltd
- DRAMINSKI S. A.
- Cortex Technology ApS
Methodology
LOADING...
